Articles
This article contains a complete list and description of every known biotech and med-tech company working on a clinical therapy for hair loss prevention/hair growth from all phases spanning research to late-stage clinical trials in 2024/2025. Over the past several years, the amount of new hair growth related technologies in development have multiplied like never…
Follicle Thought is very pleased to share this exclusive interview with the CEO of Stemson Therapeutics, Geoff Hamilton. Follicle Thought: Hi Geoff, thank you for doing this interview with Follicle Thought. To start, could you please tell us about how you met Dr. Alexey Terskikh and went on to become Stemson’s CEO? Geoff Hamilton: Well, thank…
Kintor Pharmaceutical of China brings us some timely good news today regarding its lead candidate drug KX-826 for the treatment of androgenetic alopecia. Phase 3 Will Be Soon A well respected company in the hair growth industry, Kintor Pharmaceutical, continues to outpace the competition. In a press release issued today, the company announced that KX-826…
This article covers a few companies not previously discussed online and recent happenings in hair growth related news. AddPharma of Korea Where else would new hair growth medicine be coming out of but Korea? In the case of AddPharma, it’s a mixture of “old and new”, but we’ll take it. AddPharma is a pharmaceutical company…
In this article we will cover the most prominent therapeutic candidates in the alopecia areata treatment industry in 2025. Alopecia Areata Pharmaceutical & Biotech Therapies In Development AnaptysBio – Rosnilimab or ANB030 is a Anti-PD-1 agonist. It is currently being evaluated in a 45 patient phase 2 clinical trial in moderate to severe alopecia areata.…
The company founded on Alexey Terskikh’s hair multiplication research at the Sanford Burnham Prebys Institute has not had a problem raising capital since its inception a few years ago. In a press release issued today, July, 15, 2021, Stemson Therapeutics announced the closing of a $15 million Series A financing round. DCVC-Bio and Genoa Ventures…
Perhaps the world’s most famous aging researcher, Dr. David Sinclair of Harvard University, recently revealed that his lab is working on an advanced method for hair restoration. The Sinclair Lab at Harvard Medical School Hair Growth Research Located in Boston, MA, The Sinclair Lab conducts cutting-edge research on the mechanisms of biological aging. The laboratory’s…
Today, I am pleased to introduce yet another company entering the hair growth treatment industry, Turn Biotechnologies. The company is creating therapies which restore human cells to a more youthful state and has a program targeting skin and hair. Turn Biotechnologies is one of the latest companies to make waves in the anti-aging/aging-reversal sector. The…
This article continues the recent trend of new company announcements within the hair growth treatment industry. Even better, today’s news involves a new drug entering a phase 1 clinical trial in the US. New Drug Candidate TDM-105795 TechnoDerma Medicines Inc. of China is an early-stage biotech company based in the Zhejiang Province of China. The…
New research from Stanford University may have uncovered a new useful application for hair restoration surgery. Stanford Stops The Engrailed-1 Last month in April, a research team from Stanford University headed by Dr. Michael Longaker, published a study on scarless wound healing which captured mainstream attention. The peer-reviewed study titled “Preventing Engrailed-1 activation in fibroblasts yields…